Details of the Drug

General Information of Drug (ID: DMXNI8G)

Drug Name

BMS-986156

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	The promise and challenges of immune agonist antibody development in cancer. Nat Rev Drug Discov. 2018 Jul;17(7):509-527.